Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Eitan Mor"'
Autor:
Moshe Yeshurun, Ruth Rachamimov, Liat Shargian, Eyal Fenig, Oren Pasvolsky, Pia Raanani, Michal Sela-Navon, Michal Pearl-Yafe, Jerry Stein, Eitan Mor, Moshe Israeli, Evyatar Nesher
Publikováno v:
Transplantation and Cellular Therapy. 29:S156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f870913601d7799606c7f5c9609638bd
https://doi.org/10.1016/s2666-6367(23)00268-3
https://doi.org/10.1016/s2666-6367(23)00268-3
Autor:
Pinchas Livne, Roxana Cleper, Miriam Davidovits, David Ben Meir, Irit Krause, Amit Dagan, Eitan Mor
Publikováno v:
Transplantation. 102:1014-1022
Guidelines for bladder augmentation (BA) in kidney transplantation (KT) recipients are not well-defined. In our center, simultaneous BA with KT (BA-KT) is performed. We assessed transplantation outcomes of this unique extensive procedure.A case-contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fce30161b408a65b063da29d08161de
https://doi.org/10.1097/tp.0000000000002050
https://doi.org/10.1097/tp.0000000000002050
Autor:
Irith Weissman, Eitan Mor, Ruty Rachamimov, Irit Krause, Amit Dagan, Maya Mor, Roxana Cleper, Yaakov Frishberg, Miriam Davidovits, Nathan Bar Nathan
Publikováno v:
Clinical Transplantation. 30:1324-1331
From 1982 to 2011, 53 kidney transplantations (KT) for pediatric focal segmental glomerulosclerosis (FSGS) were recorded in the National Israeli Kidney Transplant Registry (NIKTR): 22—primary (1◦) FSGS, 25—proved/suspected genetic-secondary (2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8db583b3a163388fb9dcb30380ca2d83
https://doi.org/10.1111/ctr.12825
https://doi.org/10.1111/ctr.12825
Autor:
Michal Sarfaty, Assaf Moore, Eitan Mor, Michal Cohen-Naftaly, Anna Tovar, Marius Braun, Assaf Issachar, Salomon M. Stemmer, Noa Gordon, Ofer Benjaminov
Publikováno v:
Journal of Cancer
Background & Aims: Hepatocellular Carcinoma (HCC) is the sixth most common malignancy and the third most common cause of cancer mortality worldwide. We aimed to assess the effect of novel treatment options on the survival of HCC patients. Methods: Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6f2163be8abbf028f82be7bb208adf
http://europepmc.org/articles/PMC4910579
http://europepmc.org/articles/PMC4910579
Autor:
Anat Gafter-Gvili, Boris Zingerman, Shira Schneider, Binjamin Ben-Avraham, Rachel S. Levy-Drummer, Uzi Gafter, Eitan Mor, Benaya Rozen-Zvi, Ruth Rahamimov
Publikováno v:
Nephrology. 18:148-156
Aim Haemoglobin (Hb) variability is associated with poor survival in patients with chronic kidney disease. Association of Hb variability after kidney transplantation with patients' and graft survival has not been adequetly studied. Methods This retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::448a0301fb80cee804b86c5e7c1d8b72
https://doi.org/10.1111/nep.12009
https://doi.org/10.1111/nep.12009
Autor:
Rivka Shapiro, Yaron Avitzur, Tirza Klein, Nathan Bar-Nathen, Moshe Israeli, Gabriel Dinari, Eitan Mor, Ran Steinberg, Benjamin Sredni
Publikováno v:
Liver Transplantation. 14:893-898
Lifelong immunosuppression is mandatory for optimal graft and patient survival following liver transplantation. Nevertheless, graft rejection or numerous adverse events associated with overimmunosuppression or underimmunosuppression cannot be complet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85b6646e52e2f5b2016928f8fac94a38
https://doi.org/10.1002/lt.21426
https://doi.org/10.1002/lt.21426
Publikováno v:
Transplant Immunology. 18:7-12
The survival of a transplanted organ is dependent on maintenance of continuous immunosuppression. However, even the strictest adherence to the recommended drug levels does not prevent the occurrence of numerous complications associated with immunosup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6d5b1a36f2c31ba5bf15c3ad320bda
https://doi.org/10.1016/j.trim.2007.03.005
https://doi.org/10.1016/j.trim.2007.03.005
Autor:
Eitan Mor, Marius Brown, Ran Tur-Kaspa, Jaqueline Sulkes, Lior H. Katz, Orit Pappo, Ziv Ben-Ari, N Bar-Nathan, E Shaharabani
Publikováno v:
Clinical Transplantation. 20:465-470
Recurrent hepatitis C virus (HCV) infection is particularly aggressive in the post-liver transplantation setting, with rapid progression of liver fibrosis. Biliary complications remain a significant cause of morbidity following liver transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b2b1f3e54fa1e646e92c0a6695285a5
https://doi.org/10.1111/j.1399-0012.2006.00507.x
https://doi.org/10.1111/j.1399-0012.2006.00507.x
Publikováno v:
Liver Transplantation and Surgery. 3:394-397
Reinfection with hepatitis B virus after orthotopic liver transplantation is nearly universal in patients who have not received posttransplant immunoprophylaxis. Recurrence almost invariably leads to chronic liver disease. Interferon has been used bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d577a005ba3fec2b0f7450b78573b79
https://doi.org/10.1002/lt.500030406
https://doi.org/10.1002/lt.500030406
Autor:
N Bar-Nathan, Roxana Cleper, Miriam Davidovits, Michael Berant, Maital Kaidar, Irit Krauze, Eitan Mor
Publikováno v:
Pediatric transplantation. 18(1)
Cardiovascular-related mortality is 100-fold higher in pediatric renal transplant recipients than in the age-matched general population. Seventy-seven post-renal transplant children's charts were reviewed for cardiovascular risk factors at two and si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec7f6bfd4274908cb615e56df157c2e
https://pubmed.ncbi.nlm.nih.gov/24134654
https://pubmed.ncbi.nlm.nih.gov/24134654